OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	158
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	100
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	98
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	92
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	80
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	76
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	72
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	65
Meta-analysis of a family history of diabetes in schizophrenia	61
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	55
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	50
Shortening telomere is associated with psychotic dimensions in the general population	49
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	48
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	47
Frequency of clinical appointments in subjects with emergent suicidal ideation	47
Interpersonal distance in schizophrenia: A systematic review	46
Selection bias in clinical studies of first-episode psychosis: A follow-up study	46
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	44
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	43
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	42
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	42
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	41
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	41
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	40
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	39

Issue Highlights	37
Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study	36
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	36
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	36
Hippocampus in the symptom architecture of schizophrenia spectrum disorders: A network analysis approach	34
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	34
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	34
The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study	34
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	34